Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Achieve Life Sciences Inc (NASDAQ: ACHV) closed at $2.79 down -2.45% from its previous closing price of $2.86. In other words, the price has decreased by -$2.45 from its previous closing price. On the day, 1.48 million shares were traded. ACHV stock price reached its highest trading level at $2.89 during the session, while it also had its lowest trading level at $2.74.
Ratios:
For a deeper understanding of Achieve Life Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.64 and its Current Ratio is at 6.64. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 21, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On November 14, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $12.
On September 27, 2024, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $20.Raymond James initiated its Strong Buy rating on September 27, 2024, with a $20 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 17 ’25 when Oki Mark K bought 10,000 shares for $2.89 per share. The transaction valued at 28,887 led to the insider holds 10,000 shares of the business.
Stewart Richard Alistair bought 10,000 shares of ACHV for $28,598 on Mar 17 ’25. The Chieve Executive Officer now owns 60,876 shares after completing the transaction at $2.86 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHV now has a Market Capitalization of 142582944 and an Enterprise Value of 97145864.
Stock Price History:
The Beta on a monthly basis for ACHV is 1.58, which has changed by -0.33093524 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, ACHV has reached a high of $5.31, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is 4.84%, while the 200-Day Moving Average is calculated to be -9.75%.
Shares Statistics:
For the past three months, ACHV has traded an average of 1.23M shares per day and 2214990 over the past ten days. A total of 49.69M shares are outstanding, with a floating share count of 43.28M. Insiders hold about 15.32% of the company’s shares, while institutions hold 53.95% stake in the company. Shares short for ACHV as of 1755216000 were 3980627 with a Short Ratio of 3.24, compared to 1752537600 on 2442498. Therefore, it implies a Short% of Shares Outstanding of 3980627 and a Short% of Float of 9.16.
Earnings Estimates
A detailed examination of Achieve Life Sciences Inc (ACHV) is currently in progress, with 6.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.21 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.13 and -$1.43 for the fiscal current year, implying an average EPS of -$1.26. EPS for the following year is -$0.7, with 7.0 analysts recommending between $1.31 and -$1.38.
